A UK woman is the first to receive stem cell treatment that could cure blindness. She was suffering from age-related macular degeneration (AMD) which makes up nearly half of all visual impairment in the developed world and affects up to 50 million people globally.
The UK woman underwent the procedure last month and although early days, she has not suffered any complications to date. The programme will closely monitor her for the remainder of the year and then be rolled out to a further 9 patients over the next 18 months.
Although only one patient has benefited from the process so far, this advancement in ophthalmology is a giant leap and the results are more than promising. Certainly an approach to keep a keen eye on...
“We are tremendously pleased to have reached this stage in the research for a new therapeutic approach,“ said Pete Coffey from the UCL Institute of Ophthalmology, also co-leader of the initiative. ”Although we recognise this clinical trial focuses on a small group of AMD patients who have experienced sudden severe visual loss, we hope that many patients may benefit in the future.”